The ability of bacteria to activate the terminal complement components in serum of patients with cystic fibrosis.
D001419:Bacteria; D003165:Complement System Proteins; D003550:Cystic Fibrosis / Q000150:complications / Q000276:immunology* / Q000382:microbiology; D006801:Humans; D066298:In Vitro Techniques; D008171:Lung Diseases / Q000209:etiology; D011550:Pseudomonas aeruginosa; D012008:Recurrence; D013211:Staphylococcus aureus
D003165:Complement System Proteins